BIOR Berita Valas

Biora Therapeutics Says BioJet Systemic Oral Delivery Platform Met Key Performance Milestones

Biotech company Biora Therapeutics, Inc. (BIOR) announced Tuesday that its BioJet Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration with British drug major AstraZeneca plc (AZN.L, AZN).

RTTNews | 660 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.15873	GBPUSD	1.3338	AUDUSD	0.6504
USDJPY	152.778	USDCAD	1.39967	USDCHF	0.79859